|
|
|
|
Studies of automated MRS for AD diagnosis have reported high sensitivity and moderate specificity, but are yet to test prospective samples and should be extended to include at least two MRS regions of interest. MRS has promise for predictin g cognitive status and monitoring pharmacologic efficacy, and can assess cortical and subcortical neurochemical change. |
|